Latest Edition,milk-derived tripeptides have hypotensive effects

The question of whether peptides can increase blood pressure is complex, with research suggesting a predominantly opposite effect: many peptides, particularly those derived from food proteins, are more likely to lower high blood pressure or regulate blood pressure. However, understanding the nuances of different peptide types and their mechanisms is crucial.

Research into food-derived antihypertensive peptides has been ongoing for decades. Studies have demonstrated that peptides derived from food proteins can have a significant impact on blood pressure. For instance, peptides derived from egg, chicken collagen, and rice proteins have shown a comparable blood pressure-lowering effect to that of milk-protein-derived peptides. A meta-analysis of 18 clinical trials confirmed that oral VPP and IPP peptides effectively reduce BP in hypertensive individuals, with the most pronounced effects observed in those with existing hypertension. Similarly, black soy peptide dietary supplementation significantly reduces SBP and oxidative stress in patients with prehypertension and stage I hypertension. Further research on collagen peptide supplementation also revealed that CPS significantly decreased SBP, with previous studies documenting its ability to improve blood pressure.

The mechanisms by which these peptides exert their hypotensive effects are varied. Some act on the renin-angiotensin system, which plays a critical role in blood pressure regulation. For example, whey protein-derived peptides have been shown to inhibit the synthesis of angiotensin II from angiotensin I, a process that ultimately increases blood pressure. By inhibiting this pathway, these peptides can help to lower blood pressure. Other food protein-derived antihypertensive peptides can exert their blood pressure-lowering effects through diverse pathways, including direct vasorelaxation activity. Indeed, some findings indicate that certain peptides can potentially regulate blood pressure by possessing this vasorelaxation activity.

While the majority of research points towards peptides having a blood pressure-lowering effect, it's important to consider potential exceptions and areas requiring further investigation. One study investigating an endogenous peptide found that injection into the circulation had no significant effect on the elevation of blood pressure. Furthermore, the reported effect of some peptides on reducing blood pressure in clinical trials has been described as controversial, necessitating further investigation.

Regarding specific peptides, the influence of BPC 157 on blood pressure is a topic of interest, with some users inquiring if it can raise blood pressure. However, current scientific literature does not definitively support this claim. Similarly, the direct impact of GHK-Cu on blood pressure is not extensively documented in the context of increasing it.

It is also crucial to distinguish between different types of peptides. While food-derived peptides are generally associated with blood pressure reduction, the use of unapproved injectable peptides for health and performance carries potential risks. These unregulated products have not been reviewed for safety by regulatory bodies like the FDA. Some users have reported side effects such as changes in metabolic functions which may increase the risk of hypertension and heart disease, alongside fatigue and lethargy. This highlights the importance of sourcing and using peptides responsibly.

In summary, while the general consensus and a significant body of evidence suggest that many peptides, particularly those derived from food, can lower high blood pressure and contribute to its regulation, the landscape is nuanced. The scientific community continues to explore the intricate relationship between various peptides and cardiovascular health, aiming to harness their beneficial properties while remaining vigilant about potential risks associated with unregulated or specific peptide applications. Therefore, when considering the question, can peptides increase blood pressure?, the answer leans towards no for most well-studied, naturally derived peptides, and the focus remains on their antihypertensive potential.